SciVision Biotech Inc (1786) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, SciVision Biotech Inc (1786) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$15.41 Million ≈ $485.56K USD) by net assets (NT$1.92 Billion ≈ $60.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SciVision Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how SciVision Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of SciVision Biotech Inc for a breakdown of total debt and financial obligations.

SciVision Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SciVision Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hiap Teck Venture Bhd KLSE:5072	-0.002x
Waterco Ltd AU:WAT	0.139x
Lindsell Train Investment Trust Plc LSE:LTI	0.018x
RCM Technologies Inc NASDAQ:RCMT	-0.030x
SR Bancorp, Inc. Common stock NASDAQ:SRBK	0.019x
BARK, Inc. NYSE:BARK	0.021x
Comet Ridge Ltd AU:COI	-0.051x
Rhinebeck Bancorp Inc NASDAQ:RBKB	0.016x

Annual Cash Flow Conversion Efficiency for SciVision Biotech Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of SciVision Biotech Inc from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see SciVision Biotech Inc (1786) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.90 Billion ≈ $59.77 Million	NT$269.87 Million ≈ $8.50 Million	0.142x	-14.94%
2023-12-31	NT$1.63 Billion ≈ $51.24 Million	NT$272.01 Million ≈ $8.57 Million	0.167x	+41.79%
2022-12-31	NT$1.51 Billion ≈ $47.60 Million	NT$178.21 Million ≈ $5.61 Million	0.118x	+73.60%
2021-12-31	NT$1.45 Billion ≈ $45.68 Million	NT$98.51 Million ≈ $3.10 Million	0.068x	-24.57%
2020-12-31	NT$1.40 Billion ≈ $44.24 Million	NT$126.47 Million ≈ $3.98 Million	0.090x	-40.04%
2019-12-31	NT$1.36 Billion ≈ $42.87 Million	NT$204.40 Million ≈ $6.44 Million	0.150x	+44.98%
2018-12-31	NT$1.08 Billion ≈ $33.97 Million	NT$111.70 Million ≈ $3.52 Million	0.104x	+492.97%
2017-12-31	NT$914.45 Million ≈ $28.81 Million	NT$15.98 Million ≈ $503.39K	0.017x	-59.19%
2016-12-31	NT$894.21 Million ≈ $28.17 Million	NT$38.29 Million ≈ $1.21 Million	0.043x	-18.46%
2015-12-31	NT$948.60 Million ≈ $29.89 Million	NT$49.81 Million ≈ $1.57 Million	0.053x	+2800.57%
2014-12-31	NT$1.02 Billion ≈ $32.23 Million	NT$1.85 Million ≈ $58.35K	0.002x	-94.74%
2013-12-31	NT$1.08 Billion ≈ $34.15 Million	NT$37.27 Million ≈ $1.17 Million	0.034x	-71.56%
2012-12-31	NT$425.98 Million ≈ $13.42 Million	NT$51.52 Million ≈ $1.62 Million	0.121x	+18.47%
2011-12-31	NT$363.70 Million ≈ $11.46 Million	NT$37.13 Million ≈ $1.17 Million	0.102x	+66.58%
2010-12-31	NT$111.73 Million ≈ $3.52 Million	NT$6.85 Million ≈ $215.72K	0.061x	+114.28%
2009-12-31	NT$84.09 Million ≈ $2.65 Million	NT$-36.09 Million ≈ $-1.14 Million	-0.429x	--

About SciVision Biotech Inc

TW:1786 Taiwan Medical Instruments & Supplies

Market Cap

$135.56 Million

NT$4.30 Billion TWD

Market Cap Rank

#18029 Global

#946 in Taiwan

Share Price

NT$57.50

Change (1 day)

-1.37%

52-Week Range

NT$57.50 - NT$123.00

All Time High

NT$136.50